| Literature DB >> 32545369 |
Andrea Spinazzè1, Francesca Borghi1, Daniele Magni1, Costanza Rovida2, Monica Locatelli2, Andrea Cattaneo1, Domenico Maria Cavallo1.
Abstract
This study aims to evaluate the risk assessment approach of the REACH legislation in industrial chemical departments with a focus on the use of three models to calculate exposures, and discuss those factors that can determine a bias between the estimated exposure (and therefore the expected risk) in the extended safety data sheets (e-SDS) and the expected exposure for the actual scenario. To purse this goal, the exposure estimates and risk characterization ratios (RCRs) of registered exposure scenarios (ES; "communicated exposure" and "communicated RCR") were compared with the exposure estimates and the corresponding RCRs calculated for the actual, observed ES, using recommended tools for the evaluation of exposure assessment and in particular the following tools: (i) the European Centre for Ecotoxicology and Toxicology of Chemicals Targeted Risk Assessment v.3.1 (ECETOC TRA), (ii) STOFFENMANAGER® v.8.0 and (iii) the Advanced REACH Tool (ART). We evaluated 49 scenarios in three companies handling chemicals. Risk characterization ratios (RCRs) were calculated by dividing estimated exposures by derived no-effect levels (DNELs). Although the calculated exposure and RCRs generally were lower than communicated, the correlation between communicated and calculated exposures and RCRs was generally poor, indicating that the generic registered scenarios do not reflect actual working, exposure and risk conditions. Further, some observed scenarios resulted in calculated exposure values and RCR higher than those communicated through chemicals' e-SDSs; thus 'false safe' scenarios (calculated RCRs > 1) were also observed. Overall, the obtained evidences contribute to doubt about whether the risk assessment should be performed using generic (communicated by suppliers) ES with insufficient detail of the specific scenario at all companies. Contrariwise, evidences suggested that it would be safer for downstream users to perform scenario-specific evaluations, by means of proper scaling approach, to achieve more representative estimates of chemical risk.Entities:
Keywords: ECETOC TRA; REACH; STOFFENMANAGER®; advanced REACH tool (ART); exposure scenario; occupational exposure assessment; occupational exposure models; risk characterization ratio; scaling
Mesh:
Year: 2020 PMID: 32545369 PMCID: PMC7312254 DOI: 10.3390/ijerph17114175
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Chemicals considered in this study, with their chemical abstract service number (CAS No), European community number (EC No) and number of communicated exposure situations ((N)).
| Chemical | CAS No. | EC No. | N |
|---|---|---|---|
| Morpholine | 110-91-8 | 203-815-1 | 11 |
| 2,2′-iminodiethanol (90%) | 111-42-2 | 203-868-0 | 9 |
| 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate | 4098-71-9 | 223-861-6 | 13 |
| 2,4,6-trichloro-1,3,5-triazine | 108-77-0 | 203-614-9 | 7 |
| 2-[[(butylamino)carbonyl]oxy]ethyl acrylate | 63225-53-6 | 264-036-0 | 9 |
| Total of considered Exposure Situations | 49 |
Physico-chemical properties of the chemicals considered in this study and associated reference values for each route of exposure. Note: * = DNEL/DMEL; Sources: GESTIS = substance database (IFA, Berllin, Denmark; www.dguv.de/ifa/gestis-database), PubChem = (https://pubchem.ncbi.nlm.nih.gov/); ECHE = European Chemical Agencies Registered substances factsheets (https://echa.europa.eu/search-for-chemicals); SDS = chemical’s (extended) safety data sheet, as provided by the supplier.
| Chemical | Physico-Chemical Properties | Reference Values (DNEL) | |||||
|---|---|---|---|---|---|---|---|
| MW (g/mol) | VP (Pa) | WS (mg/L) | Log Kow | Long-Term-Inhalation Exposure (Systemic Effects) (mg/m3) | Long-Term-Inhalation Exposure (Local Effects) (mg/m3) | Long-Term-Dermal Exposure (mg/kg/day) | |
| Morpholine | 87.12 | 9.80 × 102
| 1.0 × 106
| −2.55 | 91 | 36 | 1.04 |
| 2.2′-iminodiethanol (90%) | 105.14 | 8.55 × 10−3
| 1.0 × 106
| −2.00 | 0.75 | 0.5 | 0.13 |
| 3-isocyanatomethyl-3.5.5-trimethylcyclohexyl isocyanate | 222.29 (GESTIS) | 6.30 × 10-2
| 1.5 × 10 | 4.75 | 0.045 * | ||
| 2.4.6-trichloro-1.3.5-triazine | 184.41 | 6.00 × 10-3
| 4.4 × 102
| 2.14 | 0.06 | 6.94 | |
| 2-[[(butylamino)carbonyl]oxy]ethyl acrylate | 215.25 | 1.29 × 102
| 5.0 × 10−3 (SDS) | 1.82 | 9.9 | 2.0 | |
Scenarios characteristics represented by scenario name and process categories (PROC) for both the communicated scenario and observed scenario with the number (N) and percentage (%) of each descriptor.
| Variable | Communicated Scenario | Observed Scenario | ||||
|---|---|---|---|---|---|---|
|
| % |
| % | |||
| Scenario Description | Formulation and packaging/repackaging of substances and mixtures | 11 | 22.4% | Formulation and packaging/repackaging of substances and mixtures | 12 | 38.7% |
| Leather adjuvant | 9 | 18.4% | Leather adjuvant | 5 | 16.1% | |
| Use as an intermediate or monomer | 17 | 34.7% | Use as an intermediate or monomer | 6 | 19.4% | |
| Loading/filling | 3 | 6.1% | Loading/filling | 2 | 6.5% | |
| Industrial manufacture of coatings, inks, adhesives and/or other liquid formulations | 9 | 18.4% | Industrial manufacture of coatings, inks, adhesives and/or other liquid formulations | 5 | 16.1% | |
| Industrial application of coatings, inks, adhesives and/or other formulations | 1 | 3.2% | ||||
| PROC | PROC1 | 4 | 8.2% | PROC3 | 4 | 8.2% |
| PROC2 | 5 | 10.2% | PROC5 | 3 | 6.1% | |
| PROC3 | 4 | 8.2% | PROC7 | 2 | 4.1% | |
| PROC4 | 4 | 8.2% | PROC9 | 5 | 10.2% | |
| PROC5 | 2 | 4.1% | PROC10 | 3 | 6.1% | |
| PROC6 | 1 | 2.0% | PROC13 | 1 | 2.0% | |
| PROC7 | 3 | 6.1% | PROC15 | 5 | 10.2% | |
| PROC9 | 4 | 8.2% | PROC8a | 3 | 6.1% | |
| PROC10 | 3 | 6.1% | PROC8b | 5 | 10.2% | |
| PROC13 | 3 | 6.1% | NOT RELEVANT | 18 | 36.7% | |
| PROC14 | 2 | 4.1% | ||||
| PROC15 | 4 | 8.2% | ||||
| PROC8a | 4 | 8.2% | ||||
| PROC8b | 6 | 12.2% | ||||
Number (N) and percentage (%) of PROC’s characterizing parameters collected for ECETOC TRA v.3.1 in the communicated scenario and observed scenario.
| Variable | Communicated Scenario | Observed Scenario | |||
|---|---|---|---|---|---|
|
| % |
| % | ||
| Solid | Yes | 6 | 12.2 | 4 | 9.3 |
| No | 43 | 87.8 | 39 | 90.7 | |
| Dustiness of solids or VP of volatiles at process temperature | Low | 1 | 16.7 | 0 | 0 |
| Medium | 5 | 83.3 | 4 | 100 | |
| Duration of activity | <15 min | 4 | 8.2 | 0 | 0 |
| 15 min to 1 h | 4 | 8.2 | 16 | 51.6 | |
| 1–4 h | 17 | 34.7 | 8 | 25.8 | |
| >4 h | 24 | 49.0 | 7 | 22.6 | |
| Use of ventilation | Outdoor | 1 | 2.0 | 0 | 0 |
| Indoor | 29 | 59.2 | 0 | 0 | |
| Indoor + LEV | 16 | 32.7 | 23 | 74.2 | |
| Indoor + LEV + good general ventilation | 0 | 0 | 7 | 22.6 | |
| Indoor + LEV + Enhanced General Ventilation | 3 | 6.1 | 1 | 3.2 | |
| Respiratory protection efficiency | RPE Not in use | 33 | 67.3 | 0 | 0 |
| 90% | 5 | 10.2 | 27 | 87.1 | |
| 95% | 9 | 18.4 | 4 | 12.9 | |
| 99% | 2 | 4.1 | 0 | 0 | |
| Substance in preparation | <1% | 0 | 0 | 25 | 80.6 |
| 5–25% | 20 | 40.8 | 2 | 6.5 | |
| >25% | 29 | 59.2 | 4 | 12.9 | |
| Dermal PPE/Gloves | APF5 | 11 | 22.4 | 0 | 0 |
| APF10 | 32 | 65.3 | 27 | 87.1 | |
| APF20 | 6 | 12.2 | 4 | 12.9 | |
| LEV (Dermal) | Yes | 27 | 55.1 | 29 | 93.5 |
| No | 22 | 44.9 | 2 | 6.5 | |
Number of valid (N) communicated exposure estimates and associated risk characterization ratios (RCRs) for each route of exposure. SD: standard deviation; Min: minimum; Max: maximum.
| Communicated Exposures and RCRs |
| Mean | SD | Median | Min | Max | Range |
|---|---|---|---|---|---|---|---|
| Dermal Exposure (mg/kg × day) | 36 | 1.96 × 10−1 | 3.06 × 10−1 | 6.90 × 10−2 | 3.00 × 10−3 | 1.37 | 1.37 |
| RCR—dermal exposure | 33 | 2.33 × 10−1 | 2.43 × 10−1 | 1.32 × 10−1 | 5.00 × 10−3 | 8.24 × 10−1 | 8.24 × 10−1 |
| Inhalation, long-term exposure (systemic effects) (mg/m3) | 35 | 3.54 | 5.79 | 6.40 × 10−2 | 4.00 × 10−3 | 1.82 × 10 | 1.82 × 10 |
| RCR—Inhalation, long-term exposure (systemic effects) | 24 | 2.58 × 10−1 | 2.68 × 10−1 | 1.50 × 10−1 | 2.60 × 10−2 | 8.30 × 10−1 | 8.04 × 10−1 |
| Inhalation, long-term exposure (local effects) (mg/m3) | 23 | 4.31 | 6.94 | 2.80 × 10−2 | 4.00 × 10−3 | 1.82 × 10 | 1.82 × 10 |
| RCR—Inhalation, long-term exposure (local effects) | 13 | 4.21 × 10−1 | 1.77 × 10−1 | 5.11 × 10−1 | 1.54 × 10−1 | 6.13 × 10−1 | 4.59 × 10−1 |
| Inhalation, short-term exposure (local effects) (mg/m3) | 13 | 2.12 × 10−2 | 8.94 × 10−3 | 2.30 × 10−2 | 7.00 × 10−3 | 3.70 × 10−2 | 3.00 × 10−2 |
| RCR—Inhalation, short-term exposure (local effects) | 13 | 4.69 × 10−1 | 1.96 × 10−1 | 5.11 × 10−1 | 1.54 × 10−1 | 8.18 × 10−1 | 6.64 × 10−1 |
Number of valid (N) exposure estimates calculated with ECETOC TRA v.3.1 model and associated RCRs for each route of exposure evaluated. SD: standard deviation; Min: minimum; Max: maximum.
| Calculated Exposure and RCR Tool: ECETOC TRA v.3.1 |
| Mean | SD | Median | Min | Max | Range |
|---|---|---|---|---|---|---|---|
| Dermal Exposure (mg/kg × day) | 31 | 8.44 × 10−2 | 2.96 × 10−1 | 6.90 × 10−3 | 3.00 × 10−4 | 1.65 | 1.65 |
| RCR—Dermal exposure | 27 | 1.66 × 10−1 | 4.33 × 10−1 | 2.06 × 10−2 | 4.90 × 10−5 | 2.11 | 2.11 |
| Inhalation, long-term exposure (systemic effects) (mg/m3) | 31 | 7.72 × 10−2 | 1.97 × 10−1 | 2.69 × 10−2 | 3.50 × 10−5 | 1.09 | 1.09 |
| RCR—Inhalation, long-term exposure (systemic effects) | 31 | 4.20 × 10−2 | 1.33 × 10−1 | 3.50 × 10−3 | 1.00 × 10−4 | 7.20 × 10−1 | 7.20 × 10−1 |
| Inhalation, short-term exposure (local effects) (mg/m3) | 31 | 6.31 × 10−1 | 9.58 × 10−1 | 1.45 × 10−1 | 2.00 × 10−4 | 4.36 | 4.36 |
| RCR—Inhalation, short-term exposure (local effects) | 25 | 6.02 × 10−1 | 1.07 | 2.02 × 10−2 | 4.00 × 10−4 | 3.70 | 3.70 |
Number of valid (N) exposure estimates calculated with STOFFENMANAGER® v.8.0 model and associated RCRs for each route of exposure evaluated. SD: standard deviation; Min: minimum; Max: maximum.
| Calculated Exposure and RCR Tool: STOFFENMANAGER® v.8.0 |
| Mean | SD | Median | Min | Max | Range |
|---|---|---|---|---|---|---|---|
| Inhalation, long-term exposure (systemic effects) (mg/m3) | 31 | 2.45 | 5.91 | 4.0 × 10−1 | 1.70 × 10−4 | 3.25 × 10 | 3.25 × 10 |
| RCR—Inhalation, long-term exposure (systemic effects) | 31 | 2.91 | 1.09 × 10 | 3.10 × 10−2 | 2.00 × 10−3 | 5.67 × 10 | 5.67 × 10 |
| Inhalation, short-term exposure (local effects) (mg/m3) | 25 | 2.00 | 6.45 | 6.00 × 10−2 | 1.70 × 10−4 | 3.25 × 10 | 3.25 × 10 |
| RCR—Inhalation, short-term exposure (local effects) | 25 | 3.54 | 1.21 × 10 | 3.20 × 10−2 | 2.80 × 10−3 | 5.67 × 10 | 5.67 × 10 |
Number of valid (N) exposure estimates calculated with ART v.1.5 model and associated RCRs for each route of exposure evaluated. SD: standard deviation; Min: minimum; Max: maximum.
| Calculated Exposure and RCR Tool: ART v.1.5 |
| Mean | SD | Median | Min | Max | Range |
|---|---|---|---|---|---|---|---|
| Inhalation, long-term exposure (systemic effects) (mg/m3) | 23 | 3.67 | 1.49 × 10 | 3.00 × 10−2 | 2.30 × 10−4 | 7.20 × 10 | 7.20 × 10 |
| RCR—Inhalation, long-term exposure (systemic effects) | 23 | 1.14 × 10−1 | 3.37 × 10−1 | 3.00 × 10−3 | 3.10 × 10−4 | 1.47 | 1.47 |
| Inhalation, short-term exposure (local effects) (mg/m3) | 24 | 3.99 | 1.47 × 10 | 5.00 × 10−3 | 3.50 × 10−4 | 7.20 × 10 | 7.20 × 10 |
| RCR—Inhalation, short-term exposure (local effects) | 24 | 1.19 × 10 | 5.33 × 10 | 4.00 × 10−3 | 4.6 × 10−5 | 2.67 × 102 | 2.67 × 102 |
Comparison and difference between communicated exposure estimates and calculated exposure estimates with ECETOC TRA v.3.1 with associated RCRs. N: number of valid exposure estimates. SD: standard deviation.
| Communicated |
| Mean | Median | SD | Range |
|---|---|---|---|---|---|
| Dermal Exposure (mg/kg × day) | 21 | 2.24 × 10−1 | 6.90 × 10−2 | 3.53 × 10−1 | 1.37 |
| RCR—Dermal exposure | 21 | 2.35 × 10−1 | 1.32 × 10−1 | 2.40 × 10−1 | 8.20 × 10−1 |
| Inhalation, long-term exposure (systemic effects) (mg/m3) | 20 | 3.35 | 7.04 × 10−1 | 5.58 | 1.81 × 10 |
| RCR—Inhalation, long-term exposure (systemic effects) | 20 | 2.39 × 10−1 | 1.36 × 10−1 | 2.54 × 10−1 | 8.04 × 10−1 |
| Inhalation, short-term exposure (local effects) (mg/m3) | 4 | 1.78 × 10−2 | 1.80 × 10−2 | 9.50 × 10−3 | 2.10 × 10−2 |
| RCR—Inhalation, short-term exposure (local effects) | 4 | 0.39 | 0.4 | 0.21 | 0.46 |
|
|
|
|
|
|
|
| Dermal Exposure (mg/kg × day) | 25 | 3.19 × 10−2 | 6.90 × 10−3 | 6.29 × 10−2 | 2.74 × 10−1 |
| RCR—Dermal exposure | 25 | 1.38 × 10−1 | 2.06 × 10−2 | 4.55 × 10−1 | 2.11 |
| Inhalation, long-term exposure (systemic effects) (mg/m3) | 25 | 4.63 × 10−2 | 2.69 × 10−2 | 6.53 × 10−2 | 2.69 × 10−1 |
| RCR—Inhalation, long-term exposure (systemic effects) | 25 | 4.87 × 10−2 | 2.70 × 10−3 | 1.47 × 10−1 | 7.20 × 10−1 |
| Inhalation, short-term exposure (local effects) (mg/m3) | 25 | 4.92 × 10−1 | 1.45 × 10−1 | 6.35 × 10−1 | 2.15 |
| RCR—Inhalation, short-term exposure (local effects) | 25 | 6.02 × 10−1 | 2.18 × 10−2 | 1.18 | 3.70 |
|
|
|
|
|
|
|
| Dermal Exposure (mg/kg × day) | 21 | 1.90 × 10−1 | 4.00 × 10−2 | 3.60 × 10−1 | 1.57 |
| RCR—Dermal exposure | 21 | 1.00 × 10−1 | 1.00 × 10−1 | 4.30 × 10−1 | 2.36 |
| Inhalation, long-term exposure (systemic effects) (mg/m3) | 20 | 3.29 | 6.90 × 10−1 | 5.55 | 1.80 × 10 |
| RCR—Inhalation, long-term exposure (systemic effects) | 20 | 2.30 × 10−1 | 1.30 × 10−1 | 2.50 × 10−1 | 8.40 × 10−1 |
| Inhalation, short-term exposure (local effects) (mg/m3) | 4 | −9.00 × 10−2 | −1.10 × 10−1 | 6.00 × 10−2 | 1.40 × 10−1 |
| RCR—Inhalation, short-term exposure (local effects) | 4 | −2.05 | −2.55 | 1.39 | 3.08 |
Comparison and difference between communicated exposure estimates and calculated exposure estimates with STOFFENMANAGER® v.8.0 with associated RCRs. N: number of valid exposure estimates. SD: standard deviation.
| Communicated |
| Mean | Median | SD | Range |
|---|---|---|---|---|---|
| Inhalation. Long-term exposure (systemic effects) (mg/m3) | 20 | 3.35 | 7.04 × 10−1 | 5.58 | 1.81 × 10 |
| RCR—Inhalation. Long-term exposure (systemic effects) | 20 | 2.39 × 10−1 | 1.36 × 10−1 | 2.54 × 10−1 | 8.04 × 10−1 |
| Inhalation. Long-term exposure (local effects) (mg/m3) | 9 | 5.76 | 2.72 | 7.61 | 1.81 × 10 |
| RCR—Inhalation. Long-term exposure (local effects) | 9 | 3.94 × 10−1 | 4.04 × 10−1 | 2.07 × 10−1 | 4.59 × 10−1 |
|
|
|
|
|
|
|
| Inhalation. Long-term exposure (systemic effects) (mg/m3) | 25 | 2.67 | 4.00 × 10−1 | 6.54 | 3.25 × 10 |
| RCR—Inhalation. Long-term exposure (systemic effects) | 25 | 3.57 | 3.10 × 10−2 | 1.21 × 10 | 5.67 × 10 |
| Inhalation. Long-term exposure (local effects) (mg/m3) | 20 | 2.20 | 3.80 × 10−2 | 7.19 | 3.25 × 10 |
| RCR—Inhalation. Long-term exposure (local effects) | 20 | 4.38 | 3.04 × 10−2 | 1.35 × 10 | 5.67 × 10 |
|
|
|
|
|
|
|
| Inhalation. Long-term exposure (systemic effects) (mg/m3) | 20 | 0.07 | 7.75 | 0.02 | 40.84 |
| RCR—Inhalation. Long-term exposure (systemic effects) | 20 | −5.66 | 15.4 | −0.14 | 56.74 |
| Inhalation. Long-term exposure (local effects) (mg/m3) | 9 | 1.59 | 11.6 | 0.02 | 40.84 |
| RCR—Inhalation. Long-term exposure (local effects) | 9 | 0.3 | 0.13 | 0.31 | 0.32 |
Comparison and difference between communicated exposure estimates and calculated exposure estimates with ART v.1.5 with associated RCRs. N: number of valid exposure estimates. SD: standard deviation.
| Communicated |
| Mean | Median | SD | Range |
|---|---|---|---|---|---|
| Inhalation, long-term exposure (systemic effects) (mg/m3) | 20 | 3.35 | 7.04 × 10−1 | 5.58 | 1.81 × 10 |
| RCR—Inhalation, long-term exposure (systemic effects) | 20 | 2.39 × 10−1 | 1.36 × 10−1 | 2.54 × 10−1 | 8.04 × 10−1 |
| Inhalation, long-term exposure (local effects) (mg/m3) | 9 | 5.76 | 2.72 | 7.61 | 1.81 × 10 |
| RCR—Inhalation, long-term exposure (local effects) | 9 | 3.94 × 10−1 | 4.04 × 10−1 | 2.07 × 10−1 | 4.59 × 10−1 |
|
|
|
|
|
|
|
| Inhalation. Long-term exposure (systemic effects) (mg/m3) | 17 | 6.18 × 10−1 | 3.00 × 10−2 | 1.47 | 5.70 |
| RCR—Inhalation. Long-term exposure (systemic effects) | 17 | 1.56 × 10−2 | 3.03 × 10−3 | 2.73 × 10−2 | 1.00 × 10−1 |
| Inhalation. Long-term exposure (local effects) (mg/m3) | 19 | 1.20 | 4.10 × 10−3 | 2.98 | 1.20 × 10 |
| RCR—Inhalation. Long-term exposure (local effects) | 19 | 1.55 × 10 | 4.60 × 10−3 | 6.11 × 10 | 2.67 × 102 |
|
|
|
|
|
|
|
| Inhalation. Long-term exposure (systemic effects) (mg/m3) | 16 | 3.52 | 5.82 | 1.51 | 17.93 |
| RCR—Inhalation. Long-term exposure (systemic effects) | 16 | 0.14 | 0.16 | 0.05 | 0.5 |
| Inhalation. Long-term exposure (local effects) (mg/m3) | 8 | 3.84 | 9.9 | 1.7 | 29.93 |
| RCR—Inhalation. Long-term exposure (local effects) | 8 | −66.27 | 133.19 | 0.22 | 266.56 |
Regression parameters between communicated and calculated exposure and RCR. The communicated exposure estimates and RCRs were used as the independent variables and the calculated exposure estimates and RCRs were used as the dependent variable in the linear regression analysis.
| Communicated * vs. Calculated Exposure | Tool |
| Slope | Intercept | Pearson Correlation | Uncertainty | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| m | SE |
| q | SE |
| R |
| |||||
| Dermal Exposure (Mg/kg × day) | ECETOC TRA | 21 | −0.007 | 0.044 | 0.877 | 0.039 | 0.18 | 0.044 | 0.036 | 0.439 | 0.08 | 1 |
| Inhalation Long-term exposure (systemic effects) (mg/m3) | ECETOC TRA | 20 | 0.006 | 0.003 | 0.053 | 0.035 | 0.017 | 0.054 | 0.438 | 0.027 | 20.0 | 1 |
| STOFFENMANAGER® | 20 | 0.371 | 0.292 | 0.220 | 2.034 | 1.863 | 0.289 | 0.287 | 0.11 | 28.6 | 9 | |
| ART | 16 | 0.058 | 0.066 | 0.390 | 0.412 | 0.469 | 0.395 | 0.231 | 0.194 | 22.0 | 0 | |
| Inhalation Long-term exposure (local effects) (mg/m3) | STOFFENMANAGER® | 9 | 0.32 | 0.515 | 0.555 | 2.325 | 4.739 | 0.6399 | 0.228 | 0.277 | 61.0 | 1 |
| ART | 8 | −0.153 | 0.215 | 0.502 | 3.631 | 2.098 | 0.134 | 0.28 | 0.251 | 50.2 | 1 | |
| Inhalation Long-term exposure (local effects) (mg/m3) | ECETOC TRA | 4 | 3.432 | 4.305 | 0.509 | 0.049 | 0.084 | 0.619 | 0.491 | 0.254 | 0.006 | 4 |
|
|
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
|
|
| |||||
| Dermal Exposure | ECETOC TRA | 21 | 0.199 | 0.112 | 0.091 | 0.208 | 0.052 | 0.001 | 0.378 | 0.046 | 0.09 | 1 (0) |
| Inhalation Long-term exposure (systemic effects) | ECETOC TRA | 20 | 0.371 | 0.292 | 0.22 | 2.034 | 1.863 | 0.289 | −0.007 | 0.49 | 0.06 | 1 (0) |
| STOFFENMANAGER® | 20 | 2.102 | 16.828 | 0.903 | 5.399 | 5.761 | 0.366 | 0.035 | 0.451 | 127 | 8 (3) | |
| ART | 16 | 0.07 | 0.054 | 0.225 | 0.004 | 0.012 | 0.737 | 0.398 | 0.113 | 0.02 | 0 (0) | |
| Inhalation Long-term exposure (local effects) | STOFFENMANAGER® | 9 | 0.392 | 0.148 | 0.118 | −0.061 | 0.064 | 0.44 | 0.882 | 0.059 | 0.05 | 0 (0) |
| ART | 8 | −0.153 | 0.215 | 0.502 | 3.631 | 2.098 | 0.134 | 0.672 | 0.265 | 8848 | 1 (1) | |
| Inhalation Long-term exposure (local effects) | ECETOC TRA | 4 | 3.349 | 4.443 | 0.53 | 1.126 | 1.921 | 0.586 | 0.47 | 0.265 | 2.83 | 4 (3) |
Legend: N: number of data; R: Pearson correlation coefficient; p: significance; m: slope; q: intercept; SE: standard error. N underestimated exposure: number of situations in which calculated exposure > communicated exposure. N RCRcalc > RCRcom: number of situations in which calculated RCR > communicated RCR; (false safe): number of situations in which calculated RCR > 1. * Communicated exposure values and RCR were obtained through ECETOC TRA.